Fundraising Fox

Medical Devices Series C Investors & VC Firms

439 firms in this list, with a median first check of $1M. 93 of them lead rounds. Generated from verified public data and updated continuously.

B4 Capital
Pre-Seed–Late Stage$10M – $50M
2 people
Kreos Capital
LondonSeries A–Late Stage
43 people
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
41 people
Sandbox Industries
ChicagoSeed–Growth
35 people
RiverVest Venture Partners
St. LouisPre-Seed–Late Stage$500K – $3M
22 people
Main Sequence Ventures
SydneyPre-Seed–Growth
27 people
HealthCap
StockholmSeed–Growth
34 people
Calculus Capital Ltd.
LondonSeed–Late Stage$2.5M
31 people
VantagePoint Capital Partners
Silicon ValleySeed–Late Stage$2M – $100M
19 people
Ysios Capital
BarcelonaSeries A–Late Stage$5.4M – $21.6M
25 people
Innovation Industries
AmsterdamSeed–Late Stage$2.2M – $54M
25 people
UntroD Capital
TokyoPre-Seed–Growth$772K – $241M
5 people
Arc Angels
AucklandPre-Seed–Late Stage
27 people
Fortune Venture Capital
ShenzhenSeed–Late Stage$425K – $73M
11 people
Movac
AucklandSeed–Late Stage$600K – $3M
27 people
UKSE
SheffieldSeries A–Late Stage$31.8K – $1.3M
38 people
Novartis Venture Fund
BaselPre-Seed–Late Stage$5M – $25M
22 people
Claret Capital Partners
LondonSeries A–Late Stage
30 people
K2 HealthVentures
BostonSeries A–Late Stage$10M – $100M
27 people
Safar Partners
CambridgePre-Seed–Late Stage
17 people
LDC
LondonSeries B–Growth$12.7M – $127M
13 people
M Ventures
Los AngelesSeed–Growth$10.8M
6 people
Lumira Ventures
TorontoPre-Seed–Late Stage$1M – $10M
18 people
EcoR1 Capital
San FranciscoSeed–Late Stage
17 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.